SEC Form 6-K filed by LumiraDx Limited

UNITED STATES
SECURITIES AND EXCHANGE COMMISSION

Washington, D.C. 20549

FORM 6-K

REPORT OF FOREIGN PRIVATE ISSUER

PURSUANT TO RULE 13a-16 OR 15d-16

UNDER THE SECURITIES EXCHANGE ACT OF 1934

For the month of November 2023.

Commission File Number: 001-40852

LUMIRADX LIMITED

(Translation of registrant's name into English)

LumiraDx Limited
c/o Ocorian Trust (Cayman) Limited
PO Box 1350, Windward 3, Regatta Office Park
Grand Cayman KY1-1108

Cayman Islands

(354) 640-0540
(Address of principal executive office)

Indicate by check mark whether the registrant files or will file annual reports under cover of Form 20-F or Form 40-F:

Form 20-F ☒ Form 40-F ☐

EXPLANATORY NOTE

On November 6, 2023, LumiraDx Limited (the “Company”) announced that its Board of Directors (the "Board") had appointed Lurene Joseph and George Neble, each of whom is a current independent member of the Board, to serve as co-chairpersons of the Board.

Ms. Joseph is the chair of the Compensation Committee of the Board and a member of the Audit Committee. Mr. Neble is the chair of the Audit Committee of the Board.

The Company also announced the appointment of Veronique Ameye, the Company's Deputy Chief Executive Officer and General Counsel, to serve as the Company’s Chief Executive Officer and General Counsel, effective as of November 1, 2023.

This report on Form 6-K shall be deemed to be incorporated by reference into the Company’s registration statements on Form S-8 (File No. 333-259874, File No. 333-264611 and File No. 333-271538), and the registration statements on Form F-3 (File No. 333-264609 and File No. 333-271624), and to be a part thereof from the date on which this report is filed, to the extent not superseded by documents or reports subsequently furnished.

SIGNATURES

Pursuant to the requirements of the Securities Exchange Act of 1934, as amended, the registrant has duly caused this report to be signed on its behalf by the undersigned, thereunto duly authorized.